▶ 調査レポート

医薬品添加物の世界市場(~2026年)

• 英文タイトル:Global Drug Excipients Market Insights and Forecast to 2026

QYResearchが調査・発行した産業分析レポートです。医薬品添加物の世界市場(~2026年) / Global Drug Excipients Market Insights and Forecast to 2026 / MRC2-11QY05441資料のイメージです。• レポートコード:MRC2-11QY05441
• 出版社/出版日:QYResearch / 2020年11月20日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、119ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療、製薬
• 販売価格(消費税別)
  Single User¥585,000 (USD3,900)▷ お問い合わせ
  Multi User¥877,500 (USD5,850)▷ お問い合わせ
  Enterprise License¥1,170,000 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料は医薬品添加物のグローバル市場について調査・分析したレポートです。種類別(有機化学薬品、無機化学薬品、その他)市場規模、用途別(固形薬、半固形薬、液体薬)市場規模、地域別(北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等)市場規模データ、主な企業情報と企業別市場シェア等が収録されています。
・調査範囲
・エグゼクティブサマリー
・企業別医薬品添加物の競争状況、市場シェア
・世界の医薬品添加物市場:種類別市場規模 2015年-2020年(有機化学薬品、無機化学薬品、その他)
・世界の医薬品添加物市場:種類別市場規模予測 2021年-2026年(有機化学薬品、無機化学薬品、その他)
・世界の医薬品添加物市場:用途別市場規模 2015年-2020年(固形薬、半固形薬、液体薬)
・世界の医薬品添加物市場:用途別市場規模予測 2021年-2026年(固形薬、半固形薬、液体薬)
・北米の医薬品添加物市場分析:米国、カナダ
・ヨーロッパの医薬品添加物市場分析:ドイツ、フランス、イギリス、イタリア、ロシア等
・アジアの医薬品添加物市場分析:日本、中国、韓国、インド、オーストラリア、台湾等
・中南米の医薬品添加物市場分析:メキシコ、ブラジル、アルゼンチン等
・中東・アフリカの医薬品添加物市場分析:トルコ、サウジアラビア、UAE等
・企業情報(企業概要、製品概要、販売量、企業動向)
- 掲載企業(変更可能性あり):Dowdupont、Roquette、Ashland、BASF、Kerry、Evonik Industries、Croda、Associated British Foods、Archer Daniels Midland、Lubrizol、Innophos Holdings、Wacker Chemie、Signet
・地域別市場規模予測(2021年-2026年):北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場
・市場機会、課題、リスク、環境分析
・バリューチェーン、販売チャネル分析
・調査の結論

Market Analysis and Insights: Global Drug Excipients Market
The global Drug Excipients market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Drug Excipients Scope and Market Size
Drug Excipients market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Drug Excipients market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Drug Excipients market is segmented into
Organic Chemicals
Inorganic Chemicals
Others

Segment by Application, the Drug Excipients market is segmented into
Solid Drugs
Semisolid Drugs
Liquid Drugs

Regional and Country-level Analysis
The Drug Excipients market is analysed and market size information is provided by regions (countries).
The key regions covered in the Drug Excipients market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Drug Excipients Market Share Analysis
Drug Excipients market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Drug Excipients business, the date to enter into the Drug Excipients market, Drug Excipients product introduction, recent developments, etc.

The major vendors covered:
Dowdupont
Roquette
Ashland
BASF
Kerry
Evonik Industries
Croda
Associated British Foods
Archer Daniels Midland
Lubrizol
Innophos Holdings
Wacker Chemie
Signet

レポート目次

1 Study Coverage
1.1 Drug Excipients Product Introduction
1.2 Market Segments
1.3 Key Drug Excipients Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Drug Excipients Market Size Growth Rate by Type
1.4.2 Organic Chemicals
1.4.3 Inorganic Chemicals
1.4.4 Others
1.5 Market by Application
1.5.1 Global Drug Excipients Market Size Growth Rate by Application
1.5.2 Solid Drugs
1.5.3 Semisolid Drugs
1.5.4 Liquid Drugs
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Drug Excipients Market Size, Estimates and Forecasts
2.1.1 Global Drug Excipients Revenue 2015-2026
2.1.2 Global Drug Excipients Sales 2015-2026
2.2 Global Drug Excipients, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Drug Excipients Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Drug Excipients Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Drug Excipients Competitor Landscape by Players
3.1 Drug Excipients Sales by Manufacturers
3.1.1 Drug Excipients Sales by Manufacturers (2015-2020)
3.1.2 Drug Excipients Sales Market Share by Manufacturers (2015-2020)
3.2 Drug Excipients Revenue by Manufacturers
3.2.1 Drug Excipients Revenue by Manufacturers (2015-2020)
3.2.2 Drug Excipients Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Drug Excipients Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Drug Excipients Revenue in 2019
3.2.5 Global Drug Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Drug Excipients Price by Manufacturers
3.4 Drug Excipients Manufacturing Base Distribution, Product Types
3.4.1 Drug Excipients Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Drug Excipients Product Type
3.4.3 Date of International Manufacturers Enter into Drug Excipients Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Drug Excipients Market Size by Type (2015-2020)
4.1.1 Global Drug Excipients Sales by Type (2015-2020)
4.1.2 Global Drug Excipients Revenue by Type (2015-2020)
4.1.3 Drug Excipients Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Drug Excipients Market Size Forecast by Type (2021-2026)
4.2.1 Global Drug Excipients Sales Forecast by Type (2021-2026)
4.2.2 Global Drug Excipients Revenue Forecast by Type (2021-2026)
4.2.3 Drug Excipients Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Drug Excipients Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Drug Excipients Market Size by Application (2015-2020)
5.1.1 Global Drug Excipients Sales by Application (2015-2020)
5.1.2 Global Drug Excipients Revenue by Application (2015-2020)
5.1.3 Drug Excipients Price by Application (2015-2020)
5.2 Drug Excipients Market Size Forecast by Application (2021-2026)
5.2.1 Global Drug Excipients Sales Forecast by Application (2021-2026)
5.2.2 Global Drug Excipients Revenue Forecast by Application (2021-2026)
5.2.3 Global Drug Excipients Price Forecast by Application (2021-2026)

6 North America
6.1 North America Drug Excipients by Country
6.1.1 North America Drug Excipients Sales by Country
6.1.2 North America Drug Excipients Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Drug Excipients Market Facts & Figures by Type
6.3 North America Drug Excipients Market Facts & Figures by Application

7 Europe
7.1 Europe Drug Excipients by Country
7.1.1 Europe Drug Excipients Sales by Country
7.1.2 Europe Drug Excipients Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Drug Excipients Market Facts & Figures by Type
7.3 Europe Drug Excipients Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Drug Excipients by Region
8.1.1 Asia Pacific Drug Excipients Sales by Region
8.1.2 Asia Pacific Drug Excipients Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Drug Excipients Market Facts & Figures by Type
8.3 Asia Pacific Drug Excipients Market Facts & Figures by Application

9 Latin America
9.1 Latin America Drug Excipients by Country
9.1.1 Latin America Drug Excipients Sales by Country
9.1.2 Latin America Drug Excipients Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Drug Excipients Market Facts & Figures by Type
9.3 Central & South America Drug Excipients Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Drug Excipients by Country
10.1.1 Middle East and Africa Drug Excipients Sales by Country
10.1.2 Middle East and Africa Drug Excipients Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Drug Excipients Market Facts & Figures by Type
10.3 Middle East and Africa Drug Excipients Market Facts & Figures by Application

11 Company Profiles
11.1 Dowdupont
11.1.1 Dowdupont Corporation Information
11.1.2 Dowdupont Description and Business Overview
11.1.3 Dowdupont Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Dowdupont Drug Excipients Products Offered
11.1.5 Dowdupont Related Developments
11.2 Roquette
11.2.1 Roquette Corporation Information
11.2.2 Roquette Description and Business Overview
11.2.3 Roquette Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Roquette Drug Excipients Products Offered
11.2.5 Roquette Related Developments
11.3 Ashland
11.3.1 Ashland Corporation Information
11.3.2 Ashland Description and Business Overview
11.3.3 Ashland Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Ashland Drug Excipients Products Offered
11.3.5 Ashland Related Developments
11.4 BASF
11.4.1 BASF Corporation Information
11.4.2 BASF Description and Business Overview
11.4.3 BASF Sales, Revenue and Gross Margin (2015-2020)
11.4.4 BASF Drug Excipients Products Offered
11.4.5 BASF Related Developments
11.5 Kerry
11.5.1 Kerry Corporation Information
11.5.2 Kerry Description and Business Overview
11.5.3 Kerry Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Kerry Drug Excipients Products Offered
11.5.5 Kerry Related Developments
11.6 Evonik Industries
11.6.1 Evonik Industries Corporation Information
11.6.2 Evonik Industries Description and Business Overview
11.6.3 Evonik Industries Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Evonik Industries Drug Excipients Products Offered
11.6.5 Evonik Industries Related Developments
11.7 Croda
11.7.1 Croda Corporation Information
11.7.2 Croda Description and Business Overview
11.7.3 Croda Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Croda Drug Excipients Products Offered
11.7.5 Croda Related Developments
11.8 Associated British Foods
11.8.1 Associated British Foods Corporation Information
11.8.2 Associated British Foods Description and Business Overview
11.8.3 Associated British Foods Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Associated British Foods Drug Excipients Products Offered
11.8.5 Associated British Foods Related Developments
11.9 Archer Daniels Midland
11.9.1 Archer Daniels Midland Corporation Information
11.9.2 Archer Daniels Midland Description and Business Overview
11.9.3 Archer Daniels Midland Sales, Revenue and Gross Margin (2015-2020)
11.9.4 Archer Daniels Midland Drug Excipients Products Offered
11.9.5 Archer Daniels Midland Related Developments
11.10 Lubrizol
11.10.1 Lubrizol Corporation Information
11.10.2 Lubrizol Description and Business Overview
11.10.3 Lubrizol Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Lubrizol Drug Excipients Products Offered
11.10.5 Lubrizol Related Developments
11.1 Dowdupont
11.1.1 Dowdupont Corporation Information
11.1.2 Dowdupont Description and Business Overview
11.1.3 Dowdupont Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Dowdupont Drug Excipients Products Offered
11.1.5 Dowdupont Related Developments
11.12 Wacker Chemie
11.12.1 Wacker Chemie Corporation Information
11.12.2 Wacker Chemie Description and Business Overview
11.12.3 Wacker Chemie Sales, Revenue and Gross Margin (2015-2020)
11.12.4 Wacker Chemie Products Offered
11.12.5 Wacker Chemie Related Developments
11.13 Signet
11.13.1 Signet Corporation Information
11.13.2 Signet Description and Business Overview
11.13.3 Signet Sales, Revenue and Gross Margin (2015-2020)
11.13.4 Signet Products Offered
11.13.5 Signet Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Drug Excipients Market Estimates and Projections by Region
12.1.1 Global Drug Excipients Sales Forecast by Regions 2021-2026
12.1.2 Global Drug Excipients Revenue Forecast by Regions 2021-2026
12.2 North America Drug Excipients Market Size Forecast (2021-2026)
12.2.1 North America: Drug Excipients Sales Forecast (2021-2026)
12.2.2 North America: Drug Excipients Revenue Forecast (2021-2026)
12.2.3 North America: Drug Excipients Market Size Forecast by Country (2021-2026)
12.3 Europe Drug Excipients Market Size Forecast (2021-2026)
12.3.1 Europe: Drug Excipients Sales Forecast (2021-2026)
12.3.2 Europe: Drug Excipients Revenue Forecast (2021-2026)
12.3.3 Europe: Drug Excipients Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Drug Excipients Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Drug Excipients Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Drug Excipients Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Drug Excipients Market Size Forecast by Region (2021-2026)
12.5 Latin America Drug Excipients Market Size Forecast (2021-2026)
12.5.1 Latin America: Drug Excipients Sales Forecast (2021-2026)
12.5.2 Latin America: Drug Excipients Revenue Forecast (2021-2026)
12.5.3 Latin America: Drug Excipients Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Drug Excipients Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Drug Excipients Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Drug Excipients Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Drug Excipients Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Drug Excipients Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Drug Excipients Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Drug Excipients Market Segments
Table 2. Ranking of Global Top Drug Excipients Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Drug Excipients Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Organic Chemicals
Table 5. Major Manufacturers of Inorganic Chemicals
Table 6. Major Manufacturers of Others
Table 7. Global Drug Excipients Market Size Growth Rate by Application 2020-2026 (K MT)
Table 8. Global Drug Excipients Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 9. Global Drug Excipients Sales by Regions 2015-2020 (K MT)
Table 10. Global Drug Excipients Sales Market Share by Regions (2015-2020)
Table 11. Global Drug Excipients Revenue by Regions 2015-2020 (US$ Million)
Table 12. Global Drug Excipients Sales by Manufacturers (2015-2020) (K MT)
Table 13. Global Drug Excipients Sales Share by Manufacturers (2015-2020)
Table 14. Global Drug Excipients Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 15. Global Drug Excipients by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Drug Excipients as of 2019)
Table 16. Drug Excipients Revenue by Manufacturers (2015-2020) (US$ Million)
Table 17. Drug Excipients Revenue Share by Manufacturers (2015-2020)
Table 18. Key Manufacturers Drug Excipients Price (2015-2020) (USD/MT)
Table 19. Drug Excipients Manufacturers Manufacturing Base Distribution and Headquarters
Table 20. Manufacturers Drug Excipients Product Type
Table 21. Date of International Manufacturers Enter into Drug Excipients Market
Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 23. Global Drug Excipients Sales by Type (2015-2020) (K MT)
Table 24. Global Drug Excipients Sales Share by Type (2015-2020)
Table 25. Global Drug Excipients Revenue by Type (2015-2020) (US$ Million)
Table 26. Global Drug Excipients Revenue Share by Type (2015-2020)
Table 27. Drug Excipients Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 28. Global Drug Excipients Sales by Application (2015-2020) (K MT)
Table 29. Global Drug Excipients Sales Share by Application (2015-2020)
Table 30. North America Drug Excipients Sales by Country (2015-2020) (K MT)
Table 31. North America Drug Excipients Sales Market Share by Country (2015-2020)
Table 32. North America Drug Excipients Revenue by Country (2015-2020) (US$ Million)
Table 33. North America Drug Excipients Revenue Market Share by Country (2015-2020)
Table 34. North America Drug Excipients Sales by Type (2015-2020) (K MT)
Table 35. North America Drug Excipients Sales Market Share by Type (2015-2020)
Table 36. North America Drug Excipients Sales by Application (2015-2020) (K MT)
Table 37. North America Drug Excipients Sales Market Share by Application (2015-2020)
Table 38. Europe Drug Excipients Sales by Country (2015-2020) (K MT)
Table 39. Europe Drug Excipients Sales Market Share by Country (2015-2020)
Table 40. Europe Drug Excipients Revenue by Country (2015-2020) (US$ Million)
Table 41. Europe Drug Excipients Revenue Market Share by Country (2015-2020)
Table 42. Europe Drug Excipients Sales by Type (2015-2020) (K MT)
Table 43. Europe Drug Excipients Sales Market Share by Type (2015-2020)
Table 44. Europe Drug Excipients Sales by Application (2015-2020) (K MT)
Table 45. Europe Drug Excipients Sales Market Share by Application (2015-2020)
Table 46. Asia Pacific Drug Excipients Sales by Region (2015-2020) (K MT)
Table 47. Asia Pacific Drug Excipients Sales Market Share by Region (2015-2020)
Table 48. Asia Pacific Drug Excipients Revenue by Region (2015-2020) (US$ Million)
Table 49. Asia Pacific Drug Excipients Revenue Market Share by Region (2015-2020)
Table 50. Asia Pacific Drug Excipients Sales by Type (2015-2020) (K MT)
Table 51. Asia Pacific Drug Excipients Sales Market Share by Type (2015-2020)
Table 52. Asia Pacific Drug Excipients Sales by Application (2015-2020) (K MT)
Table 53. Asia Pacific Drug Excipients Sales Market Share by Application (2015-2020)
Table 54. Latin America Drug Excipients Sales by Country (2015-2020) (K MT)
Table 55. Latin America Drug Excipients Sales Market Share by Country (2015-2020)
Table 56. Latin Americaa Drug Excipients Revenue by Country (2015-2020) (US$ Million)
Table 57. Latin America Drug Excipients Revenue Market Share by Country (2015-2020)
Table 58. Latin America Drug Excipients Sales by Type (2015-2020) (K MT)
Table 59. Latin America Drug Excipients Sales Market Share by Type (2015-2020)
Table 60. Latin America Drug Excipients Sales by Application (2015-2020) (K MT)
Table 61. Latin America Drug Excipients Sales Market Share by Application (2015-2020)
Table 62. Middle East and Africa Drug Excipients Sales by Country (2015-2020) (K MT)
Table 63. Middle East and Africa Drug Excipients Sales Market Share by Country (2015-2020)
Table 64. Middle East and Africa Drug Excipients Revenue by Country (2015-2020) (US$ Million)
Table 65. Middle East and Africa Drug Excipients Revenue Market Share by Country (2015-2020)
Table 66. Middle East and Africa Drug Excipients Sales by Type (2015-2020) (K MT)
Table 67. Middle East and Africa Drug Excipients Sales Market Share by Type (2015-2020)
Table 68. Middle East and Africa Drug Excipients Sales by Application (2015-2020) (K MT)
Table 69. Middle East and Africa Drug Excipients Sales Market Share by Application (2015-2020)
Table 70. Dowdupont Corporation Information
Table 71. Dowdupont Description and Major Businesses
Table 72. Dowdupont Drug Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 73. Dowdupont Product
Table 74. Dowdupont Recent Development
Table 75. Roquette Corporation Information
Table 76. Roquette Description and Major Businesses
Table 77. Roquette Drug Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Roquette Product
Table 79. Roquette Recent Development
Table 80. Ashland Corporation Information
Table 81. Ashland Description and Major Businesses
Table 82. Ashland Drug Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Ashland Product
Table 84. Ashland Recent Development
Table 85. BASF Corporation Information
Table 86. BASF Description and Major Businesses
Table 87. BASF Drug Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. BASF Product
Table 89. BASF Recent Development
Table 90. Kerry Corporation Information
Table 91. Kerry Description and Major Businesses
Table 92. Kerry Drug Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Kerry Product
Table 94. Kerry Recent Development
Table 95. Evonik Industries Corporation Information
Table 96. Evonik Industries Description and Major Businesses
Table 97. Evonik Industries Drug Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Evonik Industries Product
Table 99. Evonik Industries Recent Development
Table 100. Croda Corporation Information
Table 101. Croda Description and Major Businesses
Table 102. Croda Drug Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Croda Product
Table 104. Croda Recent Development
Table 105. Associated British Foods Corporation Information
Table 106. Associated British Foods Description and Major Businesses
Table 107. Associated British Foods Drug Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Associated British Foods Product
Table 109. Associated British Foods Recent Development
Table 110. Archer Daniels Midland Corporation Information
Table 111. Archer Daniels Midland Description and Major Businesses
Table 112. Archer Daniels Midland Drug Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 113. Archer Daniels Midland Product
Table 114. Archer Daniels Midland Recent Development
Table 115. Lubrizol Corporation Information
Table 116. Lubrizol Description and Major Businesses
Table 117. Lubrizol Drug Excipients Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 118. Lubrizol Product
Table 119. Lubrizol Recent Development
Table 120. Innophos Holdings Corporation Information
Table 121. Innophos Holdings Description and Major Businesses
Table 122. Innophos Holdings Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. Innophos Holdings Product
Table 124. Innophos Holdings Recent Development
Table 125. Wacker Chemie Corporation Information
Table 126. Wacker Chemie Description and Major Businesses
Table 127. Wacker Chemie Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. Wacker Chemie Product
Table 129. Wacker Chemie Recent Development
Table 130. Signet Corporation Information
Table 131. Signet Description and Major Businesses
Table 132. Signet Drug Excipients Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Signet Product
Table 134. Signet Recent Development
Table 135. Global Drug Excipients Sales Forecast by Regions (2021-2026) (K MT)
Table 136. Global Drug Excipients Sales Market Share Forecast by Regions (2021-2026)
Table 137. Global Drug Excipients Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 138. Global Drug Excipients Revenue Market Share Forecast by Regions (2021-2026)
Table 139. North America: Drug Excipients Sales Forecast by Country (2021-2026) (K MT)
Table 140. North America: Drug Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 141. Europe: Drug Excipients Sales Forecast by Country (2021-2026) (K MT)
Table 142. Europe: Drug Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 143. Asia Pacific: Drug Excipients Sales Forecast by Region (2021-2026) (K MT)
Table 144. Asia Pacific: Drug Excipients Revenue Forecast by Region (2021-2026) (US$ Million)
Table 145. Latin America: Drug Excipients Sales Forecast by Country (2021-2026) (K MT)
Table 146. Latin America: Drug Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 147. Middle East and Africa: Drug Excipients Sales Forecast by Country (2021-2026) (K MT)
Table 148. Middle East and Africa: Drug Excipients Revenue Forecast by Country (2021-2026) (US$ Million)
Table 149. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 150. Key Challenges
Table 151. Market Risks
Table 152. Main Points Interviewed from Key Drug Excipients Players
Table 153. Drug Excipients Customers List
Table 154. Drug Excipients Distributors List
Table 155. Research Programs/Design for This Report
Table 156. Key Data Information from Secondary Sources
Table 157. Key Data Information from Primary Sources
List of Figures
Figure 1. Drug Excipients Product Picture
Figure 2. Global Drug Excipients Sales Market Share by Type in 2020 & 2026
Figure 3. Organic Chemicals Product Picture
Figure 4. Inorganic Chemicals Product Picture
Figure 5. Others Product Picture
Figure 6. Global Drug Excipients Sales Market Share by Application in 2020 & 2026
Figure 7. Solid Drugs
Figure 8. Semisolid Drugs
Figure 9. Liquid Drugs
Figure 10. Drug Excipients Report Years Considered
Figure 11. Global Drug Excipients Market Size 2015-2026 (US$ Million)
Figure 12. Global Drug Excipients Sales 2015-2026 (K MT)
Figure 13. Global Drug Excipients Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Drug Excipients Sales Market Share by Region (2015-2020)
Figure 15. Global Drug Excipients Sales Market Share by Region in 2019
Figure 16. Global Drug Excipients Revenue Market Share by Region (2015-2020)
Figure 17. Global Drug Excipients Revenue Market Share by Region in 2019
Figure 18. Global Drug Excipients Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Drug Excipients Revenue in 2019
Figure 20. Drug Excipients Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Drug Excipients Sales Market Share by Type (2015-2020)
Figure 22. Global Drug Excipients Sales Market Share by Type in 2019
Figure 23. Global Drug Excipients Revenue Market Share by Type (2015-2020)
Figure 24. Global Drug Excipients Revenue Market Share by Type in 2019
Figure 25. Global Drug Excipients Market Share by Price Range (2015-2020)
Figure 26. Global Drug Excipients Sales Market Share by Application (2015-2020)
Figure 27. Global Drug Excipients Sales Market Share by Application in 2019
Figure 28. Global Drug Excipients Revenue Market Share by Application (2015-2020)
Figure 29. Global Drug Excipients Revenue Market Share by Application in 2019
Figure 30. North America Drug Excipients Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Drug Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Drug Excipients Sales Market Share by Country in 2019
Figure 33. North America Drug Excipients Revenue Market Share by Country in 2019
Figure 34. U.S. Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Drug Excipients Market Share by Type in 2019
Figure 39. North America Drug Excipients Market Share by Application in 2019
Figure 40. Europe Drug Excipients Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Drug Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Drug Excipients Sales Market Share by Country in 2019
Figure 43. Europe Drug Excipients Revenue Market Share by Country in 2019
Figure 44. Germany Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Drug Excipients Market Share by Type in 2019
Figure 55. Europe Drug Excipients Market Share by Application in 2019
Figure 56. Asia Pacific Drug Excipients Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Drug Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Drug Excipients Sales Market Share by Region in 2019
Figure 59. Asia Pacific Drug Excipients Revenue Market Share by Region in 2019
Figure 60. China Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Drug Excipients Market Share by Type in 2019
Figure 83. Asia Pacific Drug Excipients Market Share by Application in 2019
Figure 84. Latin America Drug Excipients Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Drug Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Drug Excipients Sales Market Share by Country in 2019
Figure 87. Latin America Drug Excipients Revenue Market Share by Country in 2019
Figure 88. Mexico Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Drug Excipients Market Share by Type in 2019
Figure 95. Latin America Drug Excipients Market Share by Application in 2019
Figure 96. Middle East and Africa Drug Excipients Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Drug Excipients Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Drug Excipients Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Drug Excipients Revenue Market Share by Country in 2019
Figure 100. Turkey Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Drug Excipients Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Drug Excipients Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Drug Excipients Market Share by Type in 2019
Figure 107. Middle East and Africa Drug Excipients Market Share by Application in 2019
Figure 108. North America Drug Excipients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Drug Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Drug Excipients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Drug Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Drug Excipients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Drug Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Drug Excipients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Drug Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Drug Excipients Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Drug Excipients Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed